Neoplasia/BPH

	Stereotactic Body Radiotherapy vs Moderately Hypofractionated IMRT for Localized Intermediate-Risk Prostate Cancer: A Randomized Clinical Trial. JAMA Ellis RJ, Pugh SL, Yu JB, Feng FY, Konski AA, Grubb RL 3rd, Wallace RE, Gladstone DJ, Ménard C, Miccio JA, Frazier AJ, Pennington JD, Michalski JM, Spratt DE, Martinez A, Morgan SC, Mihai A, Solanki AA, Amjad A, Straza MW, Delouya G, Schroeder TM, Marshall DT, Kapadia N, Patel AN, Cescon TP, El-Gayed A, Yoon HA, Paulus R, Sandler HM, NRG-GU005 Collaborative Authors. PMID: 42593775 [PubMed - as supplied by publisher]
	Recalibrating sham-relative superiority thresholds in BPH device trials. World J Urol Polo J, Mugglin A, Bhojani N, Zorn K, Kaplan S, Elterman D, Chughtai B. PMID: 42593677 [PubMed - indexed for MEDLINE]
	Positive surgical margins after partial nephrectomy across changing surgical eras: long-term oncological results from a tertiary referral center. World J Urol Bertini A, Re C, Salerno L, Musso G, Cei F, Rosiello G, Barretta A, Belladelli F, Piccolo C, Disabato N, Campugiani A, Montesano M, Ficarra G, Tenace N, Colecchia M, Ponzoni M, Cigliola A, Necchi A, Briganti A, Bertini R, Salonia A, Montorsi F, Larcher A, Capitanio U. PMID: 42593572 [PubMed - indexed for MEDLINE]
	Real-world treatment patterns and clinical outcomes in patients with non-muscle invasive bladder cancer: a nationwide evaluation. World J Urol Raskin Y, Baekelandt F, Decaestecker K, Seront E, Grisay G, De Sutter T, Bailly M, Noujeim JP, Maes H, De Smedt L, Waltregny D, Brochier W, Roumeguère T, Tombal B. PMID: 42593560 [PubMed - indexed for MEDLINE]
	Assessing the trifecta of enucleation using Magneto laser energy on different prostate volumes in real world practice, an EAU-endourology and AUSET collaboration. World J Urol Gauhar V, Castellani D, Somani B, Goumas IK, Tan K, Sarvajit B, Fong KY, Yuen SK, Zawadzki M, Bozzini G, Herrmann T, Lim EJ. PMID: 42593553 [PubMed - indexed for MEDLINE]
	The molecular underpinnings of the immune landscape in prostate cancer: decoding a "cold" tumor. Front Oncol Li K, Yang W, Huang D. PMID: 42591989 [PubMed]
	Network analysis of core symptom changes in Chinese patients undergoing radical prostatectomy for prostate cancer: a longitudinal study. Front Oncol Huang X, Huang X, Shi Y, Li W, Zheng G. PMID: 42591611 [PubMed]
	Ambient aromatic hydrocarbons and prostate cancer: mechanistic evidence linking benzene and PAH exposure to tumor progression. Front Cell Dev Biol Wu H, Cao H, Ye Z, Li Z, Chang M, Zhang W, Xu T, Wang L, Yang T, Deng X, Hu E, Gao B. PMID: 42591383 [PubMed]
	Dietary spermidine intake is not associated with prostate cancer incidence or prostate cancer-specific mortality: findings from the prostate, lung, colorectal, and ovarian cancer screening trial. Front Nutr Wang G, Lin J, Lin Z, Jian J, Xu J, Xie J, Liu S, Chen Q, Zhong D. PMID: 42591195 [PubMed]
	Clinicopathological and molecular comparison of eosinophilic solid and cystic renal cell carcinoma and TFEB-amplified renal cell carcinoma: a comprehensive studyÂ of 15 cases. Histopathology Zullow H, Tjota MY, Kwon JW, Antic T. PMID: 42591048 [PubMed - as supplied by publisher]
	Disease-free survival as a surrogate outcome for localized kidney cancer-A systematic review and meta-analysis. Cancer Martinez C, Chen D, Leong R, Lum N, Xiao K, Almasri L, Kollmannsberger CK, Raman S. PMID: 42590929 [PubMed - indexed for MEDLINE]
	The Diagnostic and Prognostic Value of Immunohistochemical Markers in Bladder Cancer: A Real-World Study of 477 Patients. J Clin Med Tang X, Liu J, Zhao Q, Yang X, Yang Y, Du P. PMID: 42590225 [PubMed]
	The Use of Extracorporeal Organ Support Therapies for Acute Kidney Injury in Cancer Patients. J Clin Med Ati, Forni L, Premu. PMID: 42590126 [PubMed]
	Stem Cell-Delivered Cytosine Deaminase/5-Fluorocytosine and TRAIL Gene Therapy for Castration-Resistant Prostate Cancer: Translational Synthesis and First-in-Human Trial Concept. Int J Mol Sci Kim JH, Song M, Lee K, Lee SH, Song YS. PMID: 42589524 [PubMed - indexed for MEDLINE]
	Extracellular Alpha-Satellite DNA in Human Plasma as a Candidate Biomarker for Bladder Cancer Detection: Preliminary Evidence Using Digital PCR. Int J Mol Sci Santini N, Procino A, Ljubi, , Ugarkovi, Feliciello I. PMID: 42589489 [PubMed - indexed for MEDLINE]
	Matricellular Proteins in Bladder Cancer: Context-Dependent Roles in Tumor Promotion and Suppression. Int J Mol Sci Akhmetkaliyev A, Fritz García JHG, Sonnenberg-Riethmacher E, Riethmacher D. PMID: 42589463 [PubMed - indexed for MEDLINE]
	Integrative Bioinformatics and Machine Learning Analysis Identifies Novel Molecular Biomarkers in Prostate Adenocarcinoma. Int J Mol Sci Kurt HA, K, Çiçekliyurt MM, K. PMID: 42589294 [PubMed - indexed for MEDLINE]
	Survivorship Challenges in Metastatic Prostate Cancer in the Era of Prolonged Survival: A Review. Cancers (Basel) Cano Garcia C, Moryousef J, Pinthus JH, Leong DP. PMID: 42588682 [PubMed]
	Predictors of First-Line Progression-Free Survival in Testicular Germ Cell Tumors: A Retrospective Cohort Study. Cancers (Basel) Parosanu A, Nitipir C, Iaciu C, Stanciu M, Sinescu I, Baston C. PMID: 42588637 [PubMed]
	Selected Blood-Accessible Biomarkers in Prostate Cancer Radiotherapy: A PRISMA-ScR Timing-Window Framework Beyond PSA. Cancers (Basel) Gruji, Jereczek-Fossa BA, Jovanovi, , Marvaso G, Krasi, Jankovi, Peuli, Mastroleo F, Kuncman , Mutavd, Mihajlovi, Milosavljevi. PMID: 42588617 [PubMed]

Articles 1 - 20 / 190458

Page 1 of 9523



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy